I never said the product is a dud, I said there is a small and niche market for wheezo and this is who RSH is targeting, hence Cipla and other pharmacies have partnered with them as distributors to sell RSH's product to them and from the quarterly they are struggling to find buyers given the extremely small customer receipt this quarter.
Like I said, if you can prove that 15% of wheezo users are older children and adult I would eat my shoe and the FDA approval was due to "Substantial Equivalent" since previous version of wheezo had already received FDA approval many years ago (I think nearly 10 years ago when the company was under another name).
RSH Price at posting:
12.5¢ Sentiment: Hold Disclosure: Not Held
